The directions should be on the bottle. Here is the info tho, .
In clinical trials, Migranal® (dihydroergotamine mesylate, USP) Nasal Spray has been effective for the acute treatment of migraine headaches with or without aura. One spray (0.5 mg) of Migranal® (dihydroergotamine mesylate, USP) Nasal Spray should be administered in each nostril. Fifteen minutes later, an additional one spray (0.5 mg) of Migranal® (dihydroergotamine mesylate, USP) Nasal Spray should be administered in each nostril, for a total dosage of four sprays (2.0 mg) of Migranal® (dihydroergotamine mesylate, USP) Nasal Spray. Studies have shown no additional benefit from acute doses greater than 2.0 mg for a single migraine administration. The safety of doses greater than 3.0 mg in a 24 hour period and 4.0 mg in a 7 day period has not been established.
- Migranal Information for Consumers
- Migranal Information for Healthcare Professionals (includes dosage details)
- Side Effects of Migranal (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 3 Sep 2010 • 1 answer
Chronic migraines and have also recently diagnosed PTSD. What meds can be taken with current regimen
Posted 14 May 2013 • 2 answers
Posted 19 Jul 2013 • 1 answer
Posted 7 Oct 2014 • 2 answers
Posted 26 Jan 2015 • 2 answers